Targeting the mevalonate pathway for pharmacological intervention by Tsoumpra, M

BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO by Mabilleau, G, Kwaasi, A, Sabokbar, A, Tsoumpra, M, Ebetino, F, Russell, R

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate by Mabilleau, G, Kwaasi, A, Tsoumpra, M, Sabokbar, A, Dunford, J, Ebetino, F, Russell, R

Designed mutants of human farnesyl pyrophosphate synthase (FPPS) help to characterise the interactions of nitrogen-containing bisphosphonates with Tyrosine 204 and Phenylalanine 23... by Tsoumpra, M, Barnett, B, Kwaasi, A, Walters, R, Ebetino, F, Russell, R, Oppermann, U, Dunford, J

The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using en... by Tsoumpra, M, Muniz, JR, Barnett, B, Kwaasi, A, Pilka, E, Kavanagh, K, Evdokimov, A, Walter, R, Von Delft, F, Ebetino, F, Oppermann, U, Russell, G, Dunford, J

The relationship between the chemistry and biological activity of the bisphosphonates. by Ebetino, F, Hogan, A, Sun, S, Tsoumpra, M, Duan, X, Triffitt, J, Kwaasi, A, Dunford, J, Barnett, B, Oppermann, U, Lundy, M, Boyde, A, Kashemirov, B, McKenna, C, Russell, R

The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate) by Lawson, M, Ebetino, F, Mazur, A, Chantry, A, Paton-Hough, J, Evans, H, Lath, D, Tsoumpra, M, Lundy, M, Dobson, R, Quijano, M, Kwaasi, A, Dunford, J, Duan, X, Triffitt, J, Jeans, G, Russell, R